rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
2
|
pubmed:dateCreated |
2010-3-24
|
pubmed:abstractText |
Several studies confirm that botulinum toxins type A (BTX-A) are effective for reducing facial lines caused by hyperactive muscles. Two different commercial types of BTX-A currently available are BTX-A-1 (Botox) and BTX-A-2 (Dysport). This paper reports further comparison of dosing, efficacy and safety.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
1476-4180
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:volume |
12
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
106-11
|
pubmed:dateRevised |
2010-11-18
|
pubmed:meshHeading |
pubmed-meshheading:20151785-Adult,
pubmed-meshheading:20151785-Botulinum Toxins, Type A,
pubmed-meshheading:20151785-Dose-Response Relationship, Drug,
pubmed-meshheading:20151785-Drug Administration Schedule,
pubmed-meshheading:20151785-Facial Muscles,
pubmed-meshheading:20151785-Female,
pubmed-meshheading:20151785-Forehead,
pubmed-meshheading:20151785-Humans,
pubmed-meshheading:20151785-Image Processing, Computer-Assisted,
pubmed-meshheading:20151785-Injections, Subcutaneous,
pubmed-meshheading:20151785-Male,
pubmed-meshheading:20151785-Middle Aged,
pubmed-meshheading:20151785-Neuromuscular Agents,
pubmed-meshheading:20151785-Patient Satisfaction,
pubmed-meshheading:20151785-Rejuvenation,
pubmed-meshheading:20151785-Skin Aging,
pubmed-meshheading:20151785-Treatment Outcome,
pubmed-meshheading:20151785-Young Adult
|
pubmed:year |
2010
|
pubmed:articleTitle |
Dosing, efficacy and safety plus the use of computerized photography for botulinum toxins type A for upper facial lines.
|
pubmed:affiliation |
Cranley Clinic, London, UK. cranley@cranleyclinic.com
|
pubmed:publicationType |
Journal Article
|